CeQur raises $120m to advance wearable insulin patch commercialisation
CeQur Simplicity gained 510(k) clearance from the FDA for up to four days of wear in June 2024.
08 January 2025
08 January 2025
CeQur Simplicity gained 510(k) clearance from the FDA for up to four days of wear in June 2024.
The trial, which will involve around 350 patients with reduced ejection fraction, will begin enrolling in early 2025.
Nuclein plans to commence shipping of the DASH Rapid PCR System and the associated test later this month.
Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing market.
Glooko’s integration of Hedia’s diabetes tech aims to improve care for patients and enhance healthcare provider insights.
Under the partnership, the companies say they will offer clients more relevant and functional assays for drug development.
AliveCor recently introduced the Kardia 12L ECG System for healthcare professionals.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.